Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, PTC Therapeutics Inc’s stock clocked out at $46.21, down -2.10% from its previous closing price of $47.20. In other words, the price has decreased by -$2.10 from its previous closing price. On the day, 0.74 million shares were traded.
Ratios:
To gain a deeper understanding of PTCT’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.81 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 5.28. For the most recent quarter (mrq), Quick Ratio is recorded 3.85 and its Current Ratio is at 3.89.
On May 07, 2025, Citigroup Upgraded its rating to Neutral which previously was Sell but kept the price unchanged to $40.
BofA Securities Upgraded its Underperform to Neutral on March 11, 2025, whereas the target price for the stock was revised from $41 to $55.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 15 ’25 when Boulding Mark Elliott sold 1,929 shares for $46.18 per share. The transaction valued at 89,081 led to the insider holds 103,901 shares of the business.
Boulding Mark Elliott sold 883 shares of PTCT for $40,636 on May 16 ’25. The EXEC. VP AND CLO now owns 103,901 shares after completing the transaction at $46.02 per share. On May 16 ’25, another insider, Boulding Mark Elliott, who serves as the Officer of the company, bought 883 shares for $46.02 each.
Valuation Measures:
As of this moment, PTC’s Price-to-Earnings (P/E) ratio for their current fiscal year is 7.10. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.13. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.07.
Stock Price History:
Over the past 52 weeks, PTCT has reached a high of $58.38, while it has fallen to a 52-week low of $28.72. The 50-Day Moving Average of the stock is -4.59%, while the 200-Day Moving Average is calculated to be 5.75%.
Shares Statistics:
A total of 79.23M shares are outstanding, with a floating share count of 77.14M. Insiders hold about 2.67% of the company’s shares, while institutions hold 98.36% stake in the company.
